 |
|
|
|
|
Product Details:
Payment & Shipping Terms:
|
| Name: | Brivaracetam | Cas: | 357336-20-0 |
|---|---|---|---|
| Mf: | C11H20N2O2 | Purity: | 99% |
| Appearance: | White Powder | Package: | 1kg/bag Or 25kgs/drum |
| High Light: | Brivaracetam Pharmaceutical Materials,357336-20-0 Pharmaceutical Materials,Brivaracetam Active Pharmaceutical Ingredient |
||
Brain Health Drug Pharmaceutical Material Ucb 34714 CAS 357336-20-0 brivaracetam high quality
| Name | UCB 34714 |
| CAS | 357336-20-0 |
| MF | C11H20N2O2 |
| MW | 212.29 |
| EINECS | 801-184-2 |
| Appearance | white powder |
| Categories | API;Anticonvulsant;Pharmaceutical |
| Uses | UCB 34714 is an orally bioavailable levetiracetam derivative, with anticonvulsant activity. It can be used in the treatment of partial-onset seizures. |
COA
| Items | Standards | Results |
| Appearance | White or off-white crystalline powder | Complies |
| Identification | By IR | Complies |
| By HPLC | Complies | |
| Specific Optical Rotation (MeOH,c=1.0g/100mL) |
-61.0°~- 64.0° | -62.2° |
| Water Content(KF) | ≤1.00% | 0.09% |
| Heavy Metals | ≤20ppm | Complies |
| Residue on Ignition | ≤0.10% | 0.05% |
| Residual Solvents(GC) | Tert-Butyl methyl ether: ≤5000ppm | 440ppm |
| Related Substances | Sum of (R,R-isomer and S,S-isomer): ≤0.30% | 0.05% |
| Related compound 1: ≤0.10% | ND | |
| Other maximum single impurities: ≤0.10% | 0.01% | |
| Total impurities: ≤1.00% | 0.05% | |
| Related Substance Chiral(HPLC) |
R,R-Isomer: ≤0.15% | 0.01% |
| R,S-Isomer: ≤0.15% | 0.02% | |
| S,S-Isomer: ≤0.30% | 0.03% | |
| Assay (HPLC basis on drying) |
98.0%~102.0% | 99.98% |
| Reference Standard | In-house Standard | |
| Conclusion | The product complied to In-house standard. | |
| Storage | Preserve in tight,light-resistant containers in a cool place | |
Contact Person: July
Tel: 25838890
